24 maj: Torsdagens obligationer: Rutsjetur endte med et lille rentehop
24 maj: Danmark/Nationalbanken: Renten kan blive negativ - bureau
24-05-2012 17:05:00

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associate

Relateret indhold
21 aug - 
Lundbeck: Kåre Schultz køber aktier for 6 mio. kr. - NY..
20 aug - 
Torsdagens aktier: Vestas får blodigste tud i rødt C20 ..
20 aug - 
Lundbeck/Jyske: Spareplan er den rigtige medicin ..
Relateret debat
28 aug - 
Psykofarmarka, - Et Lundbech speciale. Der er andre akt..
28 aug - 
Men skal man shorte på en rød dag? Og b&os..
28 aug - 
Kender ikke aktien gider ikke saette mig ind i den.......

H. Lundbeck A/S hereby reports transactions made by executives and persons and

legal entities closely associated to them with shares in H. Lundbeck A/S and

linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's

executives today or yesterday.

Name: Anders Gersel Pedersen

Job position of the Executive Vice President &

executive: Head of Research & Development

ID code (ISIN code): DK 0010287234

Description of the Share

security:

Nature of the transaction: Transferred as part of Lundbeck’s Long Term

Incentive Program for Executive Management

Date of trading: 23 May 2012

Market on which the Nasdaq OMX Copenhagen

trading was effected:

Number of traded 33,583 shares

securities:

Persons or entities under an obligation to report are defined as members of the

Executive Management and the Supervisory Board of H. Lundbeck A/S and

persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

-- spouse or cohabitant

-- children below the age of 18

-- legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group’s

financial expectations for 2012.

Lundbeck contacts

Investors: Media:

Palle Holm Olesen Mads Kronborg

Chief Specialist, Head of Investor Relations Media Relations Manager

palo@lundbeck.com mavk@lundbeck.com

+45 36 43 24 26 +45 36 43 28 51

Magnus Thorstholm Jensen Simon Mehl Augustesen

Investor Relations Officer International Media Specialist

matj@lundbeck.com smeh@lundbeck.com

+45 36 43 38 16 +45 36 43 49 80

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is an international pharmaceutical

company highly committed to improving the quality of life for people suffering

from brain disorders. For this purpose, Lundbeck is engaged in the research,

development, production, marketing and sale of pharmaceuticals across the

world. The company’s products are targeted at disorders such as depression and

anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and

Parkinson’s diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today

Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the

world’s leading pharmaceutical companies working with brain disorders. In 2011,

the company's revenue was DKK 16.0 billion (approximately EUR 2.1 billion or

USD 3.0 billion). For more information, please visit www.lundbeck.com.

Vedhæftet fil: Release no 471_1.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
28 aug
LUN
Kender ikke aktien gider ikke saette mig ind i den...... men ret beset hvis man skal foelge dine nor..
1
28 aug
LUN
Jeg kan kun give dig ret. Personlig har jeg derfor også solgt mine Lundbeck, selv om jeg i princippe..
1
28 aug
LUN
Man må give Mikey, at han er tro mod sin analysemetode:   Den her aktie er falde meget: Den skal køb..
1
28 aug
LUN
Du må virkelig være forelsket i mig siden du følger alle mine tråde...Havde du noget fornuftigt at s..
1
28 aug
LUN
Jeg forstår slet ikke prissætningen på Lundbeck pt.   Jo vel..Kåre Schultz er en dygtig mand..og det..
1

Delårsrapport 2015 for Euroinvestor.com A/S

28-08-2015 12:51:53
Fondsbørsmeddelelse nr. 9. 2015 28. august 2015 Rekordresultat efter 1. halvår Euroinvestor.com A/S opnåede i 1. halvår 2015 en omsæt..

Novo/Leerink: Dækning indledes med "marketperform" og mål 374

28-08-2015 07:28:52
Novo Nordisk får opmærksomhed fra den amerikanske "health care"-investmentbank Leerink Partners, der indleder dækning af medicinalkoncernen med anbefalingen "ma..

Novo Nordisk køber to amerikanske virksomheder - NY

27-08-2015 15:13:31
Novo Nordisk udvider sin portefølje af projekter inden for diabetes og fedme med opkøbet af de to amerikanske forskningsvirksomheder Calibrium LLC og MB2 LLC.De..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

H Lundbeck A/S 209,20 -0,4% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2015  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
30. august 2015 21:59:36
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150824.1 - EUROWEB3 - 2015-08-30 21:59:36 - 2015-08-30 21:59:36 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x